How do I find clinical trials for my specific cancer

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Finding Clinical Trials for Your Cancer

Finding the right clinical trial can be an important part of your treatment options. Here's a practical guide to help you search:

Primary Resources to Search

1. ClinicalTrials.gov (National Institutes of Health)

  • The most comprehensive U.S. database with over 400,000 trials
  • Search by cancer type, location, and treatment approach
  • Shows trial status, eligibility criteria, and contact information
  • Free and publicly accessible

2. National Cancer Institute (NCI) Cancer Information Service

  • Call 1-800-4-CANCER (1-[phone removed]) for personalized help
  • Specialists can search trials matching YOUR specific situation
  • Available Monday-Friday, 9am-5pm ET
  • They consider your cancer type, stage, biomarkers, and location

3. NCCN (National Comprehensive Cancer Network) Member Institutions

  • NCCN Guidelines often reference relevant clinical trials
  • NCCN cancer centers often have active trials available
  • Your oncologist can access NCCN resources to identify appropriate trials

What Information You'll Need

To search effectively, gather:

  • Your specific cancer type and stage
  • Any biomarkers (like ER/PR status, HER2, BRCA mutations, PD-L1, etc.)
  • Your performance status (how well you're functioning)
  • Prior treatments you've received
  • Geographic location/willingness to travel
  • Any specific treatment approaches you're interested in

How to Evaluate Trials

When you find potential trials, ask your oncologist:

  1. "Is this trial appropriate for my specific cancer and biomarkers?"
  2. "What are the potential benefits and risks of this particular trial?"
  3. "How does this trial compare to standard treatment options for me?"
  4. "What does participation involve (visits, tests, time commitment)?"
  5. "Are there any costs, and does insurance typically cover trial-related care?"

Additional Resources

  • American Cancer Society: Cancer.org has trial-finding tools and information
  • Your Cancer Center: Ask your oncology team directly—they often know about trials before they're widely publicized
  • Disease-Specific Organizations: Groups like the Leukemia & Lymphoma Society (for blood cancers) maintain trial databases
  • Manufacturer Websites: Some pharmaceutical companies list trials for their investigational drugs

Important Considerations

  • Trials have specific eligibility requirements—not all patients qualify
  • Your oncologist's input is crucial in determining which trials are genuinely appropriate for you
  • Being in a trial doesn't mean you can't receive standard treatment
  • You can leave a trial at any time

Pro tip: Bring a list of potential trials to your next oncology appointment and discuss them with your care team. They have access to information about trials and can help determine which ones align with your specific situation.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2